Your browser doesn't support javascript.
loading
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.
Butzkueven, Helmut; Hillert, Jan; Soilu-Hänninen, Merja; Ziemssen, Tjalf; Kuhle, Jens; Wergeland, Stig; Magyari, Melinda; Berger, Joseph R; Moore, Nicholas; Aydemir, Aida; Bezemer, Irene; Sabidó, Meritxell.
Afiliação
  • Butzkueven H; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Hillert J; The Alfred Hospital, Melbourne, VIC, Australia.
  • Soilu-Hänninen M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Ziemssen T; Turku University Hospital Neurocenter and Division of Clinical Neurosciences, University of Turku, Turku, Finland.
  • Kuhle J; Center of Clinical Neuroscience, Department of Neurology, Dresden University of Technology, Dresden, Germany.
  • Wergeland S; Multiple Sclerosis Center and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.
  • Magyari M; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
  • Berger JR; Norwegian MS Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Moore N; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Aydemir A; Danish Multiple Sclerosis Center and the Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Bezemer I; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Sabidó M; Bordeaux PharmacoEpi (BPE), Université de Bordeaux, Bordeaux, France.
Curr Med Res Opin ; 39(10): 1367-1374, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37675878

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Curr Med Res Opin Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Curr Med Res Opin Ano de publicação: 2023 Tipo de documento: Article